Press Release Details

MedReleaf to collaborate with CFL Alumni Association in studying benefits of medical cannabis in managing chronic pain

24 May 2018.

MARKHAM, ON, May 24, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), today announced it will collaborate with the Canadian Football League Alumni Association ("CFLAA") in conducting an observational study on the benefits of medical cannabis in treating chronic pain and related ailments in retired professional athletes. 

MedReleaf Corp. (CNW Group/MedReleaf Corp.)

MedReleaf and the CFLAA recognize the opportunity to collaborate on this important study which will bring greater awareness to the potential health benefits of using medical cannabis in the treatment of ailments that include chronic pain. The joint observational study is scheduled to begin in the summer of 2018 with volunteer CFLAA member participants.   

"We are excited to collaborate with the CFL Alumni Association on this significant observational study with legends in the Canadian athletic arena," said Neil Closner, MedReleaf CEO. "Through ongoing research, our understanding of the benefits of medical cannabis has grown significantly and we welcome the opportunity to apply our expertise in validating new patient therapies and contributing to positive patient outcomes for this exceptional group of former athletes." 

"The CFLAA has always sought to make a difference by providing support to our alumni, many of whom experienced medical challenges following their athletic careers," said Leo Ezerins, CFLAA Executive Director.  "In collaborating with MedReleaf we hope to gain further insight into the benefits of medical cannabis in managing chronic pain - insight that could be invaluable to our almost 2,000 alumni members."


About MedReleaf Corp.

Canada's most awarded licensed producer, MedReleaf is an R&D-driven company dedicated to innovation, operational excellence and the production of top-quality cannabis.  Sourced from around the world and carefully cultivated in one of two state-of-the-art ICH-GMP and ISO 9001 certified facilities in Ontario Canada, with a third facility currently in development, premium MedReleaf products are delivered to the global medical market. MedReleaf serves the therapeutic needs of patients seeking safe, consistent and effective medical cannabis and provides a compelling product offering for the adult-use recreational consumer. 

For more information on MedReleaf, its products, research and how the company is helping patients #livefree, please visit or follow @medreleaf

About the CFLAA

The Canadian Football League Alumni Association is 2,000 members strong and unites former CFL players, from across Canada, in support of sport, youth, and health related charitable causes.  The CFLAA fosters a lifelong relationship between the Canadian Football League and its former players with a special focus on providing support to those alumni experiencing medical challenges resulting from their former athletic careers.  

SOURCE MedReleaf Corp.

Denise Riposati, Corporate Communications,, 289-317-1000 EXT. 1118